Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review

September 2021 | 46 pages | ID: FFCB0026D0CEN
GlobalData

Abstracts

Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fulgent Genetics Inc (Fulgent) is a provider of clinically diagnostic genetic testing and genetic information to physicians. The company offers a wide range of testing options through its proprietary technology platform that integrates genetic diagnostics tools with adaptive learning software, data comparison and suppression algorithms, and laboratory processes. Its major offering include genes and panels, known mutation, genomic testing, hereditary cancer, carrier screening, tumor profiling, newborn genetics and covid-19 testing. It offers genetic tests for cardiovascular and pediatric diseases, neurological disorders, cancers, and primarily serves medical institutions, hospitals in the US, Canada and other countries. Fulgent is headquartered in Temple City, California, the US.

Fulgent Genetics Inc Key Recent Developments

Aug 10,2021: Fulgent acquires CSI Laboratories to expand cancer testing expertise
Jul 26,2021: Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
May 06,2021: Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
May 06,2021: Fulgent Genetics Reports Record First Quarter Financial Results
Apr 16,2021: Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Fulgent Genetics Inc - Key Facts
Fulgent Genetics Inc - Key Employees
Fulgent Genetics Inc - Key Employee Biographies
Fulgent Genetics Inc - Major Products and Services
Fulgent Genetics Inc - History
Fulgent Genetics Inc - Company Statement
Fulgent Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Fulgent Genetics Inc - Business Description
Product Category: Institutional
Performance
Product Category: Insurance
Capital Expenditure
Product Category: Patient
Performance
Geographical Segment: Canada
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: The US
Performance
R&D Overview
Fulgent Genetics Inc - Corporate Strategy
Fulgent Genetics Inc - SWOT Analysis
SWOT Analysis - Overview
Fulgent Genetics Inc - Strengths
Fulgent Genetics Inc - Weaknesses
Fulgent Genetics Inc - Opportunities
Fulgent Genetics Inc - Threats
Fulgent Genetics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Fulgent Genetics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 26, 2021: Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
May 06, 2021: Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
May 06, 2021: Fulgent Genetics Reports Record First Quarter Financial Results
Apr 16, 2021: Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
Mar 05, 2021: Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
Mar 04, 2021: Fulgent Genetics reports record fourth quarter and full year 2020 financial results
Feb 18, 2021: Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
Jan 06, 2021: Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
Nov 23, 2020: Fulgent Genetics announces increase to full year 2020 guidance to $300 million
Nov 18, 2020: LANES, Fulgent Genetics and LA County Department of Health Services collaborate to fast-track COVID-19 test results to local healthcare providers

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Fulgent Genetics Inc, Key Facts
Fulgent Genetics Inc, Key Employees
Fulgent Genetics Inc, Key Employee Biographies
Fulgent Genetics Inc, Major Products and Services
Fulgent Genetics Inc, History
Fulgent Genetics Inc, Subsidiaries
Fulgent Genetics Inc, Key Competitors
Fulgent Genetics Inc, Ratios based on current share price
Fulgent Genetics Inc, Annual Ratios
Fulgent Genetics Inc, Annual Ratios (Cont...1)
Fulgent Genetics Inc, Annual Ratios (Cont...2)
Fulgent Genetics Inc, Interim Ratios
Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fulgent Genetics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Fulgent Genetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Fulgent Genetics Inc, Performance Chart (2016 - 2020)
Fulgent Genetics Inc, Ratio Charts
Fulgent Genetics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fulgent Genetics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021